Interferon regulatory factor 4 (IRF4) is an oncogenic transcription factor (TF) in several hematological malignancies.…
karnottJuly 9, 2026
The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients…
karnottJuly 8, 2026
In May, the Idris Lab welcomed Dr. Bartholomew Ondigo, a visiting scholar from Kenya, to…
karnottJuly 8, 2026
After nearly two decades at Harvard, neuroscientist Naoshige Uchida is preparing to take on a…
karnottJuly 7, 2026
Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating…
karnottJuly 6, 2026
Research by Katherine A. Fitzgerald, PhD, the Worcester Foundation for Biomedical Research Chair III, professor…
karnottJuly 6, 2026
The 2026 Warren Alpert Foundation Prize has been awarded to five scientists for their work…
karnottJuly 3, 2026
After nearly 20 years of meticulous research, a team of Harvard scientists has published findings…
karnottJuly 3, 2026
